# DOSTINEX
> **NDA020664** · New Drug Application · Sponsor: PFIZER · Approved 1996-12-23
## Drug
- **FDA Application Number:** NDA020664
- **Application type:** New Drug Application
- **Brand name:** DOSTINEX
- **Generic name:** CABERGOLINE
- **Active ingredients:** CABERGOLINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** PFIZER
- **Manufacturer:** Mylan Pharmaceuticals Inc.
- **First approval:** 1996-12-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020664)
---
*AI Analytics · CC0 1.0*